Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-09-04
2011-12-06
Azpuru, Carlos (Department: 1617)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
08071121
ABSTRACT:
An ophthalmically bioactive agent delivery system comprising a contact lens having dispersed therein as an oil-in-water microemulsion, an ophthalmically bioactive agent encapsulated in the oil phase, the oil phase comprising a material from which the agent VAN diffuse into and migrate through the contact lens into the post-lens tear film when the contact lens is placed on the eye and wherein the microemulsion is stabilized by the presence of a surfactant with sufficient packing at the oil-water interface to attenuate the rate of diffusion into and migration of agent through the contact lens.
REFERENCES:
patent: 4484922 (1984-11-01), Rosenwald
patent: 4668506 (1987-05-01), Bawa
patent: 5723131 (1998-03-01), Schultz et al.
patent: 6027745 (2000-02-01), Nakada et al.
patent: 6221399 (2001-04-01), Rolfes
patent: 6410045 (2002-06-01), Schultz et al.
patent: 7638137 (2009-12-01), Chauhan et al.
patent: 2004/0241207 (2004-12-01), Chauhan
Nagarsenker, M.S., Londhe, V.Y., Nadkarni, G.D., “Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery”, Int. J. of Pharm., 1990, 190: 63-71.
Lang, J.C., “Ocular drug delivery conventional ocular formulations”. Adv. Drug Delivery, 1995, 16: 39-43.
Bourlais, C.L., Acar, L., Zia H., Sado, P.A., Needham, T., Leverge, R., “Ophthalmic drug delivery systems”, Progress in retinal and eye research, 1998, 17, 1: 33-58.
Segal, M., “Patches, pumps and timed release”, FDAConsumermagazine, Oct. 1991.
Hehl, E.M., Beck, R., Luthard K., Guthoff R., “Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses”, European Journal of Clinical Pharmacology, 1999, 55 (4): 317-323.
Hillman, J. S., “Management of acute glaucoma with Pilocarpine-soaked hydrophilic lens” Brit. J. Ophthal.58 (1974) p. 674-679.
Ramer, R. and Gasset, A., “Ocular Penetration of Pilocarpine:” Ann.Ophthalmol.6, (1974) p. 1325-1327.
Montague Ruben and Watkins, Robert., “Pilocarpine dispensation for the soft hydrophilic contact lens” Brit .J. Ophthal. 59, (1975) p. 455-458.
Hillman, J.,Marsters, J. and Broad, A. “Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma” Trans. Ophthal. Soc.U. K. (1975)p. 79-84.
Giambattista, B.,Virno, M., Pecori-Giraldi, Pellegrino, N. and Motolese, E. “Possibility of Isoproterenol Therapy with Soft Contact Lenses: Ocular Hypotension Without Systemic Effects” Ann. Ophthalmol 8 (1976) p. 819-829.
Marmion, V. J. and Yardakul, S. “Pilocarpine administration by contact lens” Trans. Ophthal. Soc.U. K. 97, (1977) p. 162-3.
Elisseeff, J., McIntosh, W., Anseth, K., Riley, S., Ragan, P., Langer, R., “Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks”, Journal of Biomedical Materials Research, 2000, 51 (2): 164-171.
Ward, J. H., Peppas, N. A., “Preparation of controlled release systems by free-radical UV polymerizations in the presence of a drug”, Journal of Controlled Release, 2001, 71 (2): 183-192.
Scott, R. A., Peppas, N. A., “Highly crosslinked, PEG-containing copolymers for sustained solute delivery”, Biomaterials, 1999, 20 (15): 1371-1380.
Podual, K., Doyle F. J., Peppas N. A., “Preparation and dynamic response of cationic copolymer hydrogels containing glucose oxidase”, Polymer, 2000, 41 (11): 3975-3983.
Colombo, P., Bettini, R., Peppas, N.A., “Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug”, Journal of Controlled Release, 1999, 61 (1,2): 83-91.
Ende, M.T.A., Peppas, N.A., “Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. 2. Diffusion and release studies”, Journal of Controlled Release, 1997, 48 (1): 47-56.
Hiratani H, Alvarez-Lorenzo C—“The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems” Biomaterials 25,1105-1113, 2004.
Hiratani H, Fujiwara A, Tamiya Y, Mizutani Y, Alvarez-Lorenzo C—“Ocular release of timolol from molecularly imprinted soft contact lenses” Biomaterials 26,1293-1298, 2005.
Hiratani H, Mizutani Y, Alvarez-Lorenzo C—“Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities” Macromol Biosci 5,728-733, 2005.
Alverez-Lorenzo C, Hiratani H, Gomez-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A—“Soft contact lenses capable of sustained delivery of timolol” J Pharm Sci 91,2182-2192, 2002.
Hiratani H, Alvarez-Lorenzo C—“Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid” J Control Release 83,223-230, 2002.
Gulsen, Derya, “Ophthalmic drug delivery system”, Gulsen D, Chauhan A—“Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle”. Int J Pharm 292,95-117, 2005.
Gulsen D, Chauhan A—“Ophthalmic drug delivery through contact lenses”. Invest Ophth Vis Sci 45,2342-2347, 2004.
Graziacascone, M., Zhu, Z., Borselli, F., Lazzeri, L., “Poly(vinyl alcohol) hydrogels as hydrophilic matrices for the release of lipophilic drugs loaded in PLGA nanoparticles”, Journal of Material Science: Materials in Medicine, 2002, 13: 29-32.
Mandell, R.B., “Contact Lens Practice: Hard and Flexible Lenses”, 2nded., Charles C. Thomas, Springfield, vol. 3, 1974].
Creech, J.L., Chauhan, A., Radke, C.J., “Dispersive mixing in the posterior tear film under a soft contact lens”, I&EC Research, 2001, 40: 3015-3026.
McNamara, N.A., Polse, K.A., Brand, R.D., Graham, A.D., Chan, J.S., McKenney, C.D., “Tear mixing under a soft contact lens: Effects of lens diameter”. Am. J. of Ophth., 1999, 127(6): 659-65.
Letter from Korean Associate dated May 10, 2008, informing of Office Action issued on Apr. 27, 2008 for corresponding Korean Patent Application No. 2004-7019648 based on International application No. PCT/US03/17736 for “Ophthalmic Drug Delivery System”.
Chauhan Anuj
Gulsen Onbilger Derya
Kapoor Yash
Li Chi-Chung
Azpuru Carlos
Miles & Stockbridge P.C.
Schaffer, Esq. David R.
University of Florida Research Foundation Incorporated
LandOfFree
Dispersions of microemulsions in hydrogels for drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dispersions of microemulsions in hydrogels for drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dispersions of microemulsions in hydrogels for drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4268278